PRESS RELEASES 8/9

NEWSROOM

Feb 22, 2019

4BIO portfolio company Orchard Therapeutics announces ADA-SCID follow-on results

Nov 10, 2018

EGLSF I wins two EuroHedge Emerging Fund Management Awards

Nov 1, 2018

4BIO portfolio company Orchard Therapeutics goes public

Aug 13, 2018

4BIO portfolio company Orchard Therapeutics Announces $150 Million Series C Financing

May 10, 2018

Fellowship of the Royal Society elections

Apr 13, 2018

GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics